Scientific Software Engineer - Computational Chemistry

🕒 June 30, 2025

Apply Now

Find Similar Remote Jobs

Receive Emails For Remote Jobs

📊 Check your resume score for this job

Improve your chances of getting an interview by checking your resume score before you apply.

Upload Resume

AQEMIA

WebsiteLinkedInAll Job Openings

11 - 50 employees

💰 Series A on 2022-10

Aqemia is a pharmatech company using quantum physics and artificial intelligence to transform the drug discovery process. With a unique proprietary technology that preclude the use of experimental data, our pipeline scales the drug discovery process at an unprecedented pace, generating an exhaustive number of new drug candidates.

📋 Description

• Aqemia is a next-generation pharmatech reinventing drug discovery with quantum-inspired physics and generative AI. • As a Scientific Software Engineer you will contribute directly to building the product supporting drug hunters daily activities and accelerating Aqemia’s drug discovery programs. • You will work at the intersection of cheminformatics, software engineering, and drug discovery, designing and implementing tools that serve scientists and guide compound design decisions. • This is a key technical role with strong cross-functional impact across medicinal chemistry, physics modeling, and AI teams.

🎯 Requirements

• 2 - 4 years of experience in cheminformatics or computational chemistry, ideally in a drug discovery context • Strong programming skills in Python, experience with RDKit or similar toolkits • Familiarity with molecular descriptors, compound clustering, virtual screening, and property prediction • Good understanding of medicinal chemistry principles and compound design strategies • Experience working with data in SQL and/or NoSQL databases • Ability to communicate effectively with interdisciplinary teams and translate scientific needs into technical solutions

🏖️ Benefits

• Prime Locations : Central Paris or London offices, with 2 remote days/week • Strategic Traction :  Backed by $100M in funding and a $140M partnership with Sanofi